�
The  National  Association  of Chain  Drug  Stores  has begun lobbying House  Energy  and Commerce  Committee  leaders' staff in opposition to stricter track-and-trace rules in the wake of the recent salmonella outbreak, CongressDaily  reports. Committee  Chair  John  Dingell  (D-Mich.)  recently released a revised version of the do drugs portion of an FDA  overhaul billhook on which he is working that would pass the agency more say-so to oversee food and drug products. According  to CongressDaily,  when Dingell's  circular was low released in April,  Reps.  Steve  Buyer  (R-Ind.)  and Jim  Matheson  (D-Utah)  proposed adding a track-and-trace element -- a so-called "bloodline requirement" -- to the bill. Committee  staff members have indicated that they will not add a pedigree prerequisite unless everyone involved throne reach a consensus. 
Although  pharmaceutical distributors are "broadly speaking pleased" with the Buyer/Matheson  proposal, and the trade name and generic drug industries are "looking at for changes," representatives of the chemist's shop industry "possess dug in their heels against it," according to CongressDaily.  Lobbyists  for the pharmacy industry say the Buyer/Matheson  proposition does not account for the cost and complexity of track-and-trace technology. According  to a June  study by NACDS  and the National  Community  Pharmacists  Association,  it could cost each pharmacy as much as $110,000 in the first class to implement new track-and-trace technology. Paul  Kelly,  frailty president of government affairs for NACDS,  added that the do drugs industry -- unlike the food manufacture -- already has strong regulations and licensing that ensure the products ar safer.  NACDS  is lobbying for stronger wholesale distributor licensing standards and a requirement that FDA  administer a enfranchisement program for manufacturers, distributors and pharmacies. 
Kelly  aforementioned, "All  this talk about tracking and tracing food, we thought it was time to remind our friends that 'Hey,  they're not the same'" (Edney,  CongressDaily,  8/7).
Reprinted  with kind permission from http://www.kaisernetwork.org. You  can buoy view the entire Kaiser  Daily  Health  Policy  Report,  search the archives, or sign up for email delivery at http://www.kaisernetwork.
Thursday, 14 August 2008
Wednesday, 6 August 2008
Subscribe to:
Comments (Atom)
